Protein tyrosine phosphatase PTPN22 negatively modulates platelet function and thrombus formation.

Area of Science:

• Hematology
• Immunology
• Molecular Biology

Background:

• Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) is known to regulate T-cell signaling.
• Its expression and function in platelets have not been previously investigated.

Purpose of the Study:

• To investigate the expression and role of PTPN22 in platelet function and arterial thrombosis.

Main Methods:

• PTPN22 expression analysis in human and mouse platelets.
• Phenotyping of PTPN22 knockout mice for bleeding time and thrombosis models.
• Assessment of platelet aggregation, secretion, calcium mobilization, and spreading.
• Quantitative phosphoproteomic analysis to identify PTPN22 targets.
• Co-immunoprecipitation and in vitro phosphatase assays.
• Inhibition of PTPN22 in human platelets.

Main Results:

• PTPN22 is expressed in human and mouse platelets.
• PTPN22 deficiency accelerates arterial thrombosis and impairs hemostasis.
• PTPN22-deficient platelets show enhanced aggregation, secretion, calcium flux, and spreading.
• PTPN22 dephosphorylates phosphodiesterase 5A (PDE5A) at Ser92, impacting VASP phosphorylation.
• Purified PTPN22 exhibits serine phosphatase activity.

Conclusions:

• PTPN22 has a novel role in regulating platelet function and arterial thrombosis.
• PTPN22 acts by dephosphorylating PDE5A.
• PTPN22 inhibition enhances platelet activity, suggesting potential therapeutic targets for thrombotic disorders.